Zeo ScientifiX (ZEOX) awards stock options to Greyt Ventures LLC

Rhea-AI Filing Summary

Zeo ScientifiX, Inc. reported stock option awards to a major holder and related entity. The filing shows grants of options under the company’s 2021 Equity Incentive Plan, exercisable at an exercise price of $1.67 per share and expiring on June 10, 2036.

Footnotes explain that the options were issued to Greyt Ventures, LLC, a principal stockholder and consultant owned by a trust for which Wendy Grey is trustee. One grant vests upon achieving performance milestones, while another vested in full at the grant date, and both are exercisable on a cashless basis with anti-dilutive features tied to large future issuances.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Grey Wendy, Greyt Ventures, LLC

Role null | null

Type	Security	Shares	Price	Value
Grant/Award	Stock Options	625,000	$0.00	--
Grant/Award	Stock Options	625,000	$0.00	--

Holdings After Transaction: Stock Options — 625,000 shares (Indirect, See Footnote)

Footnotes (1)

1. Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis. Securities issued by Issuer to Greyt Ventures, LLC, a principal stockholder and consultant to the Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee. Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Plan. The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan.

Key Figures

Exercise price: $1.67 per share Option term: 10 years Expiration date: June 10, 2036 +2 more

5 metrics

Exercise price $1.67 per share Stock options under 2021 Equity Incentive Plan

Option term 10 years Options exercisable for ten years from award date

Expiration date June 10, 2036 Option expiration for reported grants

Anti-dilutive trigger 10% of common stock Antidilutive for future issuances ≥10% on fully diluted basis

Grant size per entry 625,000 options Each reported grant of stock options

Key Terms

2021 Equity Incentive Plan, cashless basis, antidilutive, fully diluted basis, +1 more

5 terms

2021 Equity Incentive Plan financial

"Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan"

cashless basis financial

"The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis""

An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.

antidilutive financial

"The options are antidilutive for any future transaction that provides for the issuance of 10% or more"

fully diluted basis financial

"10% or more of the Company's common stock outstanding on a fully diluted basis"

A fully diluted basis counts every share that could exist if all outstanding options, warrants, convertible securities and other rights were exercised or converted into common stock, showing the maximum number of shares outstanding. For investors this matters because it spreads ownership and earnings across that larger share count, like slicing a pie into every possible piece before deciding how big each investor’s slice will be, which affects per-share value and ownership percentage.

principal stockholder financial

"Securities issued by Issuer to Greyt Ventures, LLC, a principal stockholder and consultant to the Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:26 PM Accepted by SEC EDGAR 06/12/2026 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grey Wendy

(Last) (First) (Middle)

GREYT VENTURES, LLC

20533 BISCAYNE BOULEVARD, SUITE 648

(Street)

AVENTURA FLORIDA 33180

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zeo ScientifiX, Inc. [ ZEOX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$1.67	06/10/2026		A(1)		625,000		06/10/2026(1)	06/10/2036	Common Stock	625,000	$0	625,000	I	See Footnote(2)
Stock Options	$1.67	06/10/2026		A(3)		625,000		06/10/2026(3)	06/10/2036	Common Stock	625,000	$0	625,000	I	See Footnote(2)

1. Name and Address of Reporting Person^*

Grey Wendy

(Last) (First) (Middle)

GREYT VENTURES, LLC

20533 BISCAYNE BOULEVARD, SUITE 648

(Street)

AVENTURA FLORIDA 33180

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Greyt Ventures, LLC

(Last) (First) (Middle)

20533 BISCAYNE BOULEVARD,

SUITE 648

(Street)

AVENTURA FLORIDA 33180

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Equity Incentive Plan (the "2021 Plan"). The options vest upon the achievement of certain performance milestones, are exercisable on a "cashless basis" during the period commencing on the date they vest and ending ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan. The options are antidilutive for any future transaction that provides for the issuance of 10% or more of the Company's common stock outstanding on a fully diluted basis.

2. Securities issued by Issuer to Greyt Ventures, LLC, a principal stockholder and consultant to the Issuer. Greyt Ventures, LLC is owned by a trust for which Ms. Grey is trustee.

3. Represents the grant of stock options to purchase shares of the Issuer's common stock under its 2021 Plan. The options vested in full as of the grant date, are exercisable on a "cashless basis" for a period of ten (10) years from the award date, and are subject to the other terms and conditions of the 2021 Plan.

	/s/ Wendy Grey	06/12/2026
	/s/ Wendy Grey, Manager	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Zeo ScientifiX (ZEOX) report in this Form 4?

Zeo ScientifiX reported grants of stock options under its 2021 Equity Incentive Plan. The options were awarded to Greyt Ventures, LLC, a principal stockholder and consultant, with Wendy Grey as trustee of the owning trust, and are exercisable on a cashless basis.

Who received the Zeo ScientifiX (ZEOX) stock options disclosed in this filing?

The stock options were issued to Greyt Ventures, LLC, described as a principal stockholder and consultant to Zeo ScientifiX. Footnotes state Greyt Ventures, LLC is owned by a trust for which Wendy Grey serves as trustee, linking the awards to a ten percent owner.

What are the key terms of the Zeo ScientifiX (ZEOX) option grants?

The options carry an exercise price of $1.67 per share and expire on June 10, 2036. They are exercisable on a cashless basis, were granted under the 2021 Equity Incentive Plan, and remain subject to that plan’s other terms and conditions.

How do the Zeo ScientifiX (ZEOX) options vest for Greyt Ventures, LLC?

One option grant vests upon achieving specified performance milestones, while another vested in full on the grant date. Both sets of options are exercisable on a cashless basis for ten years from the award date, consistent with the 2021 Equity Incentive Plan terms.

What is the anti-dilutive feature mentioned in the Zeo ScientifiX (ZEOX) option grants?

Footnotes state the options are antidilutive for any future transaction that issues at least 10% of Zeo ScientifiX common stock on a fully diluted basis. This means the option grants are structured not to increase dilution if such large future issuances occur.